Retrospective Investigation of Pediatric Histoplasmosis Diagnosed at a Tertiary Children’s Hospital in an Endemic Area Over 11 Years
Journal of the Pediatric Infectious Diseases Society · 2025
DOI: 10.1093/jpids/piaf007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Lina Al-Tahhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States. Hauptthemen laut MEDLINE: Histoplasmosis, Endemic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Most histoplasmosis data are from adults. We describe pediatric histoplasmosis diagnosed at a tertiary pediatric care center in an endemic area.
Methods
We performed a retrospective chart review of patients birth-18 years seen in our institution (January 1, 2010 to August 15, 2022) with histoplasmosis identified by International Classification of Disease codes. We performed descriptive and univariate analyses of demographic, historical, clinical, laboratory, and treatment data.
Results
Of 122 patients, 26 had disseminated histoplasmosis (DH), 71 pulmonary/thoracic (P/T) disease, 21 had histoplasmosis as an incidental finding, and 4 were classified as other. Median age was 14 years (range 0.3–18.7 years); most were non-Hispanic White (70.5%) and city dwellers (77.1%). We noted neither seasonality nor disease category differences for age, race and ethnicity, residence, or environmental factors. Compared to P/T, DH more frequently had complex chronic conditions (73.1% vs 12.7%, P < .001), fever (88.5% vs 52.1%, P < .001), fatigue (76.9% vs 46.5%, P = .01), vomiting (53.8% vs 25.3%, P = .01), anemia (hemoglobin median 10.05 vs 12.5 g/dL, P < .001), elevated sedimentation rate values (median 31 vs 29 mm/h, P = .02), blood and urine Histoplasma antigen detection (63.6/84.6% vs 20.0/14.8%, P < .001), and antifungal treatment (100% vs 70.4%, P < .001). Patients with DH had longer antifungal treatment courses (399 vs 84 days, P < .001). Exposures were rarely recorded, but the most common was chickens. Chest radiographs were less likely to show adenopathy in DH compared to P/T (8.7% vs 55%, P < .001).
Conclusions
Presentations, risk factors, diagnostics use/results, and therapy for pediatric histoplasmosis most often parallel those in adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States.
- Department of Health Services and Outcomes Research, Children's Mercy Kansas City, Kansas City, MO, United States.
- Department of Pediatrics, Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, MO, United States.
ORCID-Profile: Christopher J Harrison, Rana E El Feghaly
Zitieren
APA
Al-Tahhan, L., Harrison, C. J., Lee, B. R., & El Feghaly, R. E. (2025). Retrospective Investigation of Pediatric Histoplasmosis Diagnosed at a Tertiary Children’s Hospital in an Endemic Area Over 11 Years. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf007
Vancouver
Al-Tahhan L, Harrison CJ, Lee BR, El Feghaly RE. Retrospective Investigation of Pediatric Histoplasmosis Diagnosed at a Tertiary Children’s Hospital in an Endemic Area Over 11 Years. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf007
BibTeX
@article{AlTahhan2025,
author = {Al-Tahhan, Lina and Harrison, Christopher J and Lee, Brian R and El Feghaly, Rana E},
title = {Retrospective Investigation of Pediatric Histoplasmosis Diagnosed at a Tertiary Children’s Hospital in an Endemic Area Over 11 Years},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2025},
doi = {10.1093/jpids/piaf007}
}
EUVIMED